Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec;33(12):2948.e1-2948.e10.
doi: 10.1016/j.neurobiolaging.2012.06.017. Epub 2012 Jul 20.

Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in southern Italy

Affiliations

Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in southern Italy

Livia Bernardi et al. Neurobiol Aging. 2012 Dec.

Abstract

The objectives of this study were to estimate frontotemporal dementia (FTD) prevalence, identify FTD-related mutations, and correlate FTD phenotype with mutations in a southern Italian population. The study population consisted of subjects ≥ 50 years of age residing in the Community of Biv. on January 1, 2004, and a door-to-door 2-phase design was used. Genetic and biochemical analyses were done on samples collected from 32 patients. Prevalence rates were 0.6 for Alzheimer's disease, 0.4 for vascular dementia (VD), 3.5 for FTD, 0.2 for Parkinson dementia, and 1.2 for unspecified dementia. Three GRN (1 known and 2 novel) mutations with reduced plasma protein levels were found associated to 3 distinct phenotypes (behavioral, affective, and delirious type). We report an unusually high FTD prevalence in the investigated population, but a low prevalence of Alzheimer's disease. We confirm the heterogeneity of FTD phenotype associated with different GRN mutations.

PubMed Disclaimer

Conflict of interest statement

statement All authors report no disclosures and no actual or potential conflicts of interest.

Figures

Figure 1
Figure 1
A. Plasma GRN levels in FTD mutated patients and controls; B. Age at onset in GRN_positive and GRN_negative patients
Figure 2
Figure 2
Symptoms and neurological signs at onset in the GRN mutations carriers (in the FTD patients)
Figure 3
Figure 3
Symptoms and neurological signs at manifest stage in the GRN mutation carriers (in FTD patients)

References

    1. Andreasen N, Blennow K, Sjodin C, Winblad B, Svardsudd K. Prevalence and Incidence of Clinically diagnoses memory impairments in a geographically defined general population in Sweden. Neuroepidemiology. 1999;18:144–155. - PubMed
    1. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916–919. - PubMed
    1. Beck J, Rohrer JD, Campbell T, Isaacs A, Morrison KE, Goodall EF, Warrington EK, Stevens J, Revesz T, Holton J, Al-Sarraj S, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain. 2008;131(Pt3):706–720. - PMC - PubMed
    1. Borroni B, Alberici A, Grassi M, Turla M, Zanetti O, Bianchetti A, Dalla Volta G, Rozzini R, Gilberti N, Bellelli G, Padovani A. Is frontotemporal lobar degeneration a rare disorder? Evidence from a preliminary study in Brescia county, Italy. J Alzheimer Dis. 2010;19:111–116. - PubMed
    1. Brun A, Englund B, Gustafson L. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994;57:416–418. - PMC - PubMed

MeSH terms